Diets, Lipoproteins and Inflammation Markers
Effectiveness of Vegan Diet and MyPlate Diet (Taiwanese Version) on Lipoproteins, Novel Markers of Cardiovascular Diseases, and Traditional Cardiometabolic Risk Factors
1 other identifier
interventional
21
1 country
1
Brief Summary
Systematic inflammation and lipid profiles are two major therapeutic targets for cardiovascular diseases. The effectiveness of vegan diet has been reported (doi: 10.3389/fnut.2022.807810). Aim: To compare the effectiveness of a nutritionally balanced vegan diet and a Myplate diet ((Taiwanese version) on systematic inflammation and lipoprotein subclass. Design: Randomized crossover design
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable cardiovascular-diseases
Started Jul 2017
Shorter than P25 for not_applicable cardiovascular-diseases
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 18, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 14, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
June 15, 2018
CompletedFirst Submitted
Initial submission to the registry
May 30, 2022
CompletedFirst Posted
Study publicly available on registry
June 21, 2022
CompletedFebruary 21, 2023
June 1, 2019
11 months
May 30, 2022
February 17, 2023
Conditions
Outcome Measures
Primary Outcomes (7)
Novel inflammatory markers for cardiovascular disease and Lipoprotein particles concentration
GlycA (umol/L), lipoprotein particles concentration(umol/L)
12 weeks
Lipoprotein particles concentration
lipoprotein particles concentration (nmol/L)
12 weeks
lipoprotein particles size
lipoprotein particles size (nm)
12 weeks
Trimethylamine-N-oxide
TMAO (uM). TMAO is a low molecular weight compound that belongs to the class of amine oxides
12 weeks
Traditional cadiometabolic risk factors 1
TG(mg/dL), LDL-C(mg/dL), HDL-C(mg/dL), Total cholesterol(mg/dL)
12 weeks
Traditional cadiometabolic risk factors 2
HbA1c(%)
12 weeks
Traditional cadiometabolic risk factors 3
HOMA-IR index (Homeostasis Model Assessment-Insulin Resistance index)
12 weeks
Study Arms (2)
Vegan diet
EXPERIMENTALParticipants were provided with and instructed to eat these foods: * flaxseed meal, * walnuts, * pecans, * extra-virgin olive oil, * Brazil nuts * Taiwanese purple laver (also known as "hong-mao-tai" or Bangia atropurpurea, and was selected to test for its vitamin B12 bioavailability). Each Participant has three group sessions and three individual nutrition counseling with a dietitian.
MyPlate (Taiwanese version)
ACTIVE COMPARATOREach Participant has three group sessions and three individual nutrition counseling with a dietitian.
Interventions
The participants were advised to eat foods in their original type.
Eligibility Criteria
You may qualify if:
- Patients with dyslipidemia (at least one of the following)
- TG ≥ 150 mg/dL
- TC ≥ 200 mg/dL
- LDL-c≥ 130 mg/dL,
- HDL-c \< 45 mg/dL for male or \< 55 mg/dL for female or receiving statin treatment
You may not qualify if:
- chronic kidney disease
- history of coronary artery disease
- ischemic heart disease,
- heart failure,
- stroke,
- cancer of any type
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hualien Tzu Chi Hospital
Hualien City, Taiwan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 30, 2022
First Posted
June 21, 2022
Study Start
July 18, 2017
Primary Completion
June 14, 2018
Study Completion
June 15, 2018
Last Updated
February 21, 2023
Record last verified: 2019-06
Data Sharing
- IPD Sharing
- Will not share